Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
$26.4 Billion Amgen Buyout Sends Horizon Stock Soaring
09:36am, Monday, 12'th Dec 2022
The shares of Horizon Therapeutics PLC (NASDAQ:HZNP) are up 14.9% at $111.75 this morning, following reports that Amgen (AMGN) will buy the biopharmaceutical company in a deal worth roughly $26.4 bill
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
09:11am, Monday, 12'th Dec 2022
Amgen announced a $28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher. The post Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion D
Amgen to buy Horizon Therapeutics for $116.50 per share
08:11am, Monday, 12'th Dec 2022
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.
Amgen to Buy Horizon Therapeutics
08:11am, Monday, 12'th Dec 2022
Amgen reaches a deal to buy drug company Horizon Therapeutics for $116.50 a share in cash.
Amgen confirms US$26bn swoop for Horizon Therapeutics
07:39am, Monday, 12'th Dec 2022
US biotechnology giant Amgen, Inc confirmed weekend speculation that it will be acquiring Horizon Therapeutics by formally unveiling a US$26.4bn swoop for the rare diseases drug maker. This will be
Amgen (AMGN) To Buy Horizon Therapeutics (HZNP) For $26.4 Billion
07:30am, Monday, 12'th Dec 2022
Amgen (AMGN) announced it is buying Horizon Therapeutics (HZNP) for $26.4 billion. These are the details.
Amgen reportedly in talks to buy Horizon Therapeutics
06:36am, Monday, 12'th Dec 2022 MarketWatch
The U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.
Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billion
06:15am, Monday, 12'th Dec 2022
Amgen Inc. AMGN, -2.42% said Monday it has agreed to acquire Horizon Therapeutics Plc HZNP, +0.39% in an all-cash deal valued at $27.8 billion, confirming earlier reports and a deal that was first moo
Amgen to Buy Horizon Therapeutics for $116.50 a Share
06:11am, Monday, 12'th Dec 2022
Amgen reaches a deal to buy drug company Horizon Therapeutics for $116.50 a share in cash.
AMGEN TO HOST WEBCAST INVESTOR CALL FOLLOWING ANNOUNCED ACQUISITION OF HORIZON THERAPEUTICS
06:05am, Monday, 12'th Dec 2022
THOUSAND OAKS, Calif. , Dec. 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community following the announced acquisition of Horizon Therapeutics at 8:00 a.m.
Amgen Said to Agree to $26 Billion Purchase of Horizon
05:52am, Monday, 12'th Dec 2022
Amgen Inc. has agreed to buy Horizon Therapeutics Plc, offering around $116.5 for each Horizon share at a valuation of about $26 billion. Aaron Kirchfeld reports on Bloomberg Television.
Amgen set to buy biotech firm Horizon at $26 bln valuation - Bloomberg News
02:50am, Monday, 12'th Dec 2022
Amgen Inc is set to buy biotech firm Horizon Therapeutics Plc at a valuation of about $26 billion in what would be its largest acquisition, Bloomberg News reported on Monday.
Amgen reportedly in talks to buy Horizon Therapeutics
01:36am, Monday, 12'th Dec 2022
Amgen Inc. is in advanced talks to buy drug company Horizon Therapeutics PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark t
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
02:15pm, Sunday, 11'th Dec 2022 The Motley Fool
Amgen recently shared positive clinical trial results for a heart disease drug candidate.
Amgen Nears Deal to Buy Horizon Therapeutics
02:11pm, Sunday, 11'th Dec 2022
The U.S. biotech company was the last of three suitors standing in an auction for Horizon. A deal would likely be valued at well over $20 billion and mark the largest healthcare merger of the year.
